← Back to headlines
Pulse Biosciences slips despite Q4 beat after deal to sell shares
Pulse Biosciences saw its stock decline despite reporting better-than-expected fourth-quarter earnings, following a deal to sell shares.
20 Feb, 15:22 — 20 Feb, 15:22
ℹOnly 1 source covers this story
